Research & Development
European Commission approves Sobi's Aspaveli for rare kidney diseases
16 January 2026 - Swedish biopharmaceutical company Sobi (STO: SOBI) said on Friday that the European Commission has approved Aspaveli (pegcetacoplan) for use in adults and adolescents aged 12 to 17 w...
Sun Pharma announces US availability of UNLOXCYT (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma
16 January 2026 - Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA, BSE:524715), an India-based specialty generic drug company, announced on Thursday that UNLOXCYT (cosibelimab-ipdl) is now availa...
US FDA accepts IND application for AskBio's AB-1009
15 January 2026 - Gene therapy specialist AskBio Inc, a wholly owned and independently operated subsidiary of German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY), announced...
EspeRare and n-Lorem partner to expand European access to ASO therapies for rare genetic diseases
14 January 2026 - Non-profit organisations the EspeRare Foundation, based in Switzerland, and US-based n-Lorem Foundation on Wednesday announced a strategic collaboration to expand access in Europe to...
Bionpharma and STEERLife's Etravirine tablets approved by US FDA
14 January 2026 - STEERLife, the life sciences division of India-based STEER World, and Bionpharma Inc, a US-based pharmaceutical company, announced on Tuesday that Bionpharma has received Abbreviated...
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
13 January 2026 - Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a US-based wearable medical device and digital healthcare company, announced on Tuesday that it has entered a strategic collaboratio...